A combined experimental and mathematical approach for molecular-based optimization of irinotecan circadian delivery.
Circadian timing largely modifies efficacy and toxicity of many anticancer drugs. Recent findings suggest that optimal circadian delivery patterns depend on the patient genetic background. We present here a combined experimental and mathematical approach for the design of chronomodulated administrat...
Guardado en:
Autores principales: | Annabelle Ballesta, Sandrine Dulong, Chadi Abbara, Boris Cohen, Alper Okyar, Jean Clairambault, Francis Levi |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2c16131466da4f039d02a5470af19687 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanistic insights into p53‐regulated cytotoxicity of combined entinostat and irinotecan against colorectal cancer cells
por: Christian Marx, et al.
Publicado: (2021) -
KML001 displays vascular disrupting properties and irinotecan combined antitumor activities in a murine tumor model.
por: Chang Hoon Moon, et al.
Publicado: (2013) -
Nanomedicine developments in the treatment of metastatic pancreatic cancer: focus on nanoliposomal irinotecan
por: Ko AH
Publicado: (2016) -
Blood-brain barrier disruption and delivery of irinotecan in a rat model using a clinical transcranial MRI-guided focused ultrasound system
por: Nathan McDannold, et al.
Publicado: (2020) -
Chronic circadian disruption modulates breast cancer stemness and immune microenvironment to drive metastasis in mice
por: Eva Hadadi, et al.
Publicado: (2020)